It may be interesting to find out whether or not blood NfHSMI35 were therefore useful to improve prognostic accuracy in patients with AQP4 seropositive ON [17, 21] or in patients with NMO in whom isolated peaks in serial antibody titres suggest active disease [22]. The gene discussed is AQP4; the disease is neuromyelitis optica.